Mrv1909 12022222402D 17 17 0 0 1 0 999 V2000 -0.2691 -3.4225 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.4454 -3.8350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1598 -3.4225 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 1.1598 -2.5975 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.8743 -3.8350 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 1.8743 -4.6600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5888 -5.0725 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.5888 -3.4225 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.3033 -3.8350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.0177 -3.4225 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 4.1040 -2.6020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.9109 -2.4305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.3234 -3.1450 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 4.7714 -3.7581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.9429 -4.5650 0.0000 N 0 3 0 0 0 0 0 0 0 0 0 0 5.7276 -4.8200 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 4.3298 -5.1171 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 3 2 1 0 0 0 0 3 4 1 1 0 0 0 3 5 1 0 0 0 0 5 6 1 0 0 0 0 6 7 1 0 0 0 0 5 8 1 1 0 0 0 8 9 1 0 0 0 0 9 10 1 0 0 0 0 10 11 1 0 0 0 0 11 12 2 0 0 0 0 12 13 1 0 0 0 0 13 14 2 0 0 0 0 10 14 1 0 0 0 0 14 15 1 0 0 0 0 15 16 1 0 0 0 0 15 17 2 0 0 0 0 M CHG 2 15 1 16 -1 M END > DB17304 > drugbank > OC[C@@H](O)[C@H](CO)OCN1C=CN=C1[N+]([O-])=O > InChI=1S/C8H13N3O6/c12-3-6(14)7(4-13)17-5-10-2-1-9-8(10)11(15)16/h1-2,6-7,12-14H,3-5H2/t6-,7+/m1/s1 > FIITXXIVUIXYMI-RQJHMYQMSA-N > C8H13N3O6 > 247.207 > 247.080435151 > 7 > 30 > 0.5242972215783639 > 22.49474836542491 > 1 > 3 > 0 > 0 > (2R,3S)-3-[(2-nitro-1H-imidazol-1-yl)methoxy]butane-1,2,4-triol > -1.49 > -1.184960409 > -1.20 > 0 > 0 > 1 > 0 > 14.64593704691099 > 13.309506606884232 > 0.03760110908585415 > 130.88 > 53.7736 > 7 > 1 > 1.55e+01 g/l > (2R,3S)-3-[(2-nitroimidazol-1-yl)methoxy]butane-1,2,4-triol > 0 > DB17304 > investigational > Doranidazole > (2rs,3sr)-3-((2-nitroimidazol-1-yl)methoxy)butane-1,2,4-triol; 1,2,4-butanetriol, 3-((2-nitro-1h-imidazol-1-yl)methoxy)-, (2r,3s)-rel- $$$$